FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Barry Arnason

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Anatomy

Procedures

Sympathectomy, Chemical

Physiology

Lymphocyte Activation

Co-author Network

Publications

TOP 3
Carl E Stafstrom; Barry G W Arnason; Tallie Z Baram; Anna Catania; Miguel A Cortez; Tracy A Glauser; Michael R Pranzatelli; Raili Riikonen; Michael A Rogawski; Shlomo Shinnar; John W Swann
Treatment of infantile spasms: emerging insights from clinical and basic science perspectives.
David M White; Mark A Jensen; Eric A Johnson; Sabine Pellett; William H Tepp; Barry G W Arnason
Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells.
Ahmad Othman; David M Frim; Paul Polak; Snezana Vujicic; Barry G W Arnason; Anne I Boullerne
Olig1 is expressed in human oligodendrocytes during maturation and regeneration.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Barry Arnason (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Carl E Stafstrom; Barry G W Arnason; Tallie Z Baram; Anna Catania; Miguel A Cortez; Tracy A Glauser; Michael R Pranzatelli; Raili Riikonen; Michael A Rogawski; Shlomo Shinnar; John W Swann
Treatment of infantile spasms: emerging insights from clinical and basic science perspectives.
Journal of child neurology 2011;26(11):1411-21.
2011: David M White; Mark A Jensen; Eric A Johnson; Sabine Pellett; William H Tepp; Barry G W Arnason
Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells.
Infection and immunity 2011;79(8):3388-96.
2011: Ahmad Othman; David M Frim; Paul Polak; Snezana Vujicic; Barry G W Arnason; Anne I Boullerne
Olig1 is expressed in human oligodendrocytes during maturation and regeneration.
Glia 2011;59(6):914-26.
2010: Mark A Jensen; Rachel N Yanowitch; Anthony T Reder; David M White; Barry G W Arnason
Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b.
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(1):30-8.
2009: Betty Soliven; Kourosh Rezania; Betul Gundogdu; Barbara Harding-Clay; Joel Oger; Barry G W Arnason
Terbutaline in myasthenia gravis: a pilot study.
Journal of the neurological sciences 2009;277(1-2):150-4.
2007: Mark A Jensen; Barry G W Arnason; David M White
A novel Fc gamma receptor ligand augments humoral responses by targeting antigen to Fc gamma receptors.
European journal of immunology 2007;37(4):1139-48.
2006: Kourosh Rezania; Barry G W Arnason; Betty Soliven
Patterns and significance of concomitant central and peripheral inflammatory demyelination.
Neurological research 2006;28(3):326-33.
2005: Barry G W Arnason
Long-term experience with interferon beta-1b (Betaferon)in multiple sclerosis.
Journal of neurology 2005;252 Suppl 3():iii28-iii33.
2003: D S Goodin; Barry G W Arnason; Patricia K Coyle; E M Frohman; D W Paty
The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Neurology 2003;61(10):1332-8.
2002: Jack S Burks; Barry G W Arnason; Patricia K Coyle; Corey C Ford; Avertano Noronha; Kottil W. Rammohan
Issues and practices in multiple sclerosis.
Neurorehabilitation and neural repair 2002;16(4):307-20.
2002: Anne I Boullerne; Jose J Rodriguez; Tarik Touil; Bruno Brochet; Stephan Schmidt; Nora D Abrous; Michel Le Moal; Jeffrey R Pua; Mark A Jensen; Willy Mayo; Barry G W Arnason; Klaus G Petry
Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(1):123-32.
2001: David M White; Mark A Jensen; X Shi; Barry G W Arnason
Design and expression of polymeric immunoglobulin fusion proteins: a strategy for targeting low-affinity Fcgamma receptors.
Protein expression and purification 2001;21(3):446-55.
2001: Z X Qu; Neil H Pliskin; M W Jensen; D White; Barry G W Arnason
Etretinate augments interferon beta-1b effects on suppressor cells in multiple sclerosis.
Archives of neurology 2001;58(1):87-90.
1999: E C Schorr; Barry G W Arnason
Interactions between the sympathetic nervous system and the immune system.
Brain, behavior, and immunity 1999;13(4):271-8.
1999: Barry G W Arnason
Treatment of multiple sclerosis with interferon beta.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1999;53(8):344-50.
1999: Mark A Jensen; A Dayal; Barry G W Arnason
Cytokine secretion by deltagamma and alphabeta T cells in monophasic experimental autoimmune encephalomyelitis.
Journal of autoimmunity 1999;12(2):73-80.
1999: Barry G W Arnason
Immunologic therapy of multiple sclerosis.
Annual review of medicine 1999;50():291-302.
1998: E Chelmicka-Schorr; K Wiegmann; Robert Wollmann; Barry G W Arnason; D H Kim
Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats.
Journal of autoimmunity 1998;11(4):329-34.
1998: Barry G W Arnason; Ferdinando Dianzani
Correlation of the appearance of anti-interferon antibodies during treatment and dimunition of efficacy: summary of an International Workshop on Anti-Interferon Antibodies.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1998;18(8):639-44.
1998: Z X Qu; A Dayal; Mark A Jensen; Barry G W Arnason
All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis.
Archives of neurology 1998;55(3):315-21.
1997: David M White; Teiji Takeda; Leslie J DeGroot; K Stefansson; Barry G W Arnason
Beta-trace gene expression is regulated by a core promoter and a distal thyroid hormone response element.
The Journal of biological chemistry 1997;272(22):14387-93.
1997: Barry G W Arnason; A Toscas; A Dayal; Z Qu; Avertano Noronha
Role of interferons in demyelinating diseases.
Journal of neural transmission. Supplementum 1997;49():117-23.
1996: Neil H Pliskin; D P Hamer; David S Goldstein; Vernon L Towle; Anthony T Reder; A Noronha; Barry G W Arnason
Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b.
Neurology 1996;47(6):1463-8.
1996: Mark A Jensen; Barry G W Arnason; A Toscas; A Noronha
Global inhibition of IL-2 and IFN-gamma secreting T cells precedes recovery from acute monophasic experimental autoimmune encephalomyelitis.
Journal of autoimmunity 1996;9(5):587-97.
1996: Barry G W Arnason
Interferon beta in multiple sclerosis.
Clinical immunology and immunopathology 1996;81(1):1-11.
1996: Barry G W Arnason; A Dayal; Z X Qu; Mark A Jensen; K Genç; Anthony T Reder
Mechanisms of action of interferon-beta in multiple sclerosis.
Springer seminars in immunopathology 1996;18(1):125-48.
1995: A S Dayal; Mark A Jensen; Alberto LLedo; Barry G W Arnason
Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b.
Neurology 1995;45(12):2173-7.
1995: S Muthyala; K Wiegmann; D H Kim; Barry G W Arnason; E Chelmicka-Schorr
Experimental allergic encephalomyelitis, beta-adrenergic receptors and interferon gamma-secreting cells in beta-adrenergic agonist-treated rats.
International journal of immunopharmacology 1995;17(11):895-901.
1995: Barry G W Arnason
The role of cytokines in multiple sclerosis.
Neurology 1995;45(6 Suppl 6):S54-5.
1995: Anthony T Reder; Barry G W Arnason
Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue.
Neurology 1995;45(6):1097-100.
1995: K Wiegmann; S Muthyala; D H Kim; Barry G W Arnason; E Chelmicka-Schorr
Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats.
Journal of neuroimmunology 1995;56(2):201-6.
1994: E Chelmicka-Schorr; Barry G W Arnason
Nervous system-immune system interactions and their role in multiple sclerosis.
Annals of neurology 1994;36 Suppl():S29-32.
1993: Gianvito Martino; B L DuPont; Robert L Wollmann; Paolo Bongioanni; J Anastasi; J Quintans; Barry G W Arnason; L M Grimaldi
The human-severe combined immunodeficiency myasthenic mouse model: a new approach for the study of myasthenia gravis.
Annals of neurology 1993;34(1):48-56.
1993: C Z Lu; Mark A Jensen; Barry G W Arnason
Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis.
Journal of neuroimmunology 1993;46(1-2):123-8.
1993: Gianvito Martino; L M Grimaldi; Robert L Wollmann; Paolo Bongioanni; J Quintans; Barry G W Arnason
The hu-SCID myasthenic mouse. A new tool for the investigation of seronegative myasthenia gravis.
Annals of the New York Academy of Sciences 1993;681():303-5.
1992: Mark A Jensen; Barry G W Arnason; A Toscas; A Noronha
Preferential increase of IL-2R+ CD4+ T cells and CD45RB- CD4+ T cells in the central nervous system in experimental allergic encephalomyelitis.
Journal of neuroimmunology 1992;38(3):255-61.
1992: B Anlar; J W Karaszewski; Anthony T Reder; Barry G W Arnason
Increased muscarinic cholinergic receptor density on CD4+ lymphocytes in progressive multiple sclerosis.
Journal of neuroimmunology 1992;36(2-3):171-7.
1991: J W Karaszewski; Anthony T Reder; B Anlar; W C Kim; Barry G W Arnason
Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell.
Annals of neurology 1991;30(1):42-7.
1991: Anthony T Reder; Barry G W Arnason; D Maimone; D Rohwer-Nutter
The function of the CD2 protein is abnormal in multiple sclerosis.
Journal of autoimmunity 1991;4(3):479-91.
1991: D Maimone; S Gregory; Barry G W Arnason; Anthony T Reder
Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis.
Journal of neuroimmunology 1991;32(1):67-74.
1991: Barry G W Arnason
Nervous system-immune system communication.
Reviews of infectious diseases 1991;13 Suppl 1():S134-7.
1990: J W Karaszewski; Anthony T Reder; Ricardo A Maselli; M Brown; Barry G W Arnason
Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis.
Annals of neurology 1990;27(4):366-72.
1990: E Chelmicka-Schorr; M E Checinski; Barry G W Arnason
Sympathetic nervous system and PC12 pheochromocytoma-derived factors suppress stimulation of lymphocytes.
Brain, behavior, and immunity 1990;4(1):23-9.
1990: M K Nicholas; A G Chenelle; M M Brown; Kari Stefansson; Barry G W Arnason
Prevention of neural allograft rejection in the mouse following in vivo depletion of L3T4+ but not LYT-2+ T-lymphocytes.
Progress in brain research 1990;82():161-7.
1990: E Chelmicka-Schorr; Barry G W Arnason
Nervous system-immune system interactions.
Research publications - Association for Research in Nervous and Mental Disease 1990;68():67-90.
1989: E Chelmicka-Schorr; M N Kwasniewski; B E Thomas; Barry G W Arnason
The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats.
Journal of neuroimmunology 1989;25(2-3):203-7.
1989: E Chelmicka-Schorr; M E Checinski; Barry G W Arnason
PC12 pheochromocytoma and sympathetic nervous system derived trophic factors augment growth of neuroblastoma.
European journal of cancer & clinical oncology 1989;25(7):1057-9.
1988: E Chelmicka-Schorr; M Checinski; Barry G W Arnason
Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis.
Journal of neuroimmunology 1988;17(4):347-50.
1988: E Chelmicka-Schorr; M Checinski; Barry G W Arnason
Sympathectomy augments the severity of experimental allergic encephalomyelitis in rats.
Annals of the New York Academy of Sciences 1988;540():707-8.
1988: Barry G W Arnason; A B Noronha; Anthony T Reder
Immunoregulation in rapidly progressive multiple sclerosis.
Annals of the New York Academy of Sciences 1988;540():4-12.
1988: Barry G W Arnason; M Brown; Ricardo A Maselli; J Karaszewski; Anthony T Reder
Blood lymphocyte beta-adrenergic receptors in multiple sclerosis.
Annals of the New York Academy of Sciences 1988;540():585-8.
1987: S Neely; R Rosenberg; Jean-Paul Spire; J Antel; Barry G W Arnason
HLA antigens in narcolepsy.
Neurology 1987;37(12):1858-60.
1987: M K Nicholas; J P Antel; Kari Stefansson; Barry G W Arnason
Rejection of fetal neocortical neural transplants by H-2 incompatible mice.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(7):2275-83.
1987: Barry G W Arnason
Autoimmune neuropathies.
Annals of the New York Academy of Sciences 1987;505():313-8.
1986: E Chelmicka-Schorr; M E Checinski; K H Jones; R C Yu; Barry G W Arnason
Sympathetic nervous system trophism for neuroblastoma and its age dependence in rats.
Cancer research 1986;46(11):5504-6.
1986: R L Kinnard; E Chelmicka-Schorr; M E Checinski; K H Jones; Barry G W Arnason
Sympathetic nervous system and glioma growth.
European journal of cancer & clinical oncology 1986;22(4):501-3.
1985: E Chelmicka-Schorr; K H Jones; M E Checinski; R C Yu; Barry G W Arnason
Influence of the sympathetic nervous system on the growth of neuroblastoma in vivo and in vitro.
Cancer research 1985;45(12 Pt 1):6213-5.
1985: E Chelmicka-Schorr; R C Yu; M G Sportiello; Barry G W Arnason
Sympathetic ganglia augment growth of neuroblastoma in vitro.
European journal of cancer & clinical oncology 1985;21(8):957-64.
1985: K Miles; E Chelmicka-Schorr; S Atweh; G Otten; Barry G W Arnason
Sympathetic ablation alters lymphocyte membrane properties.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(2 Suppl):797s-801s.
1984: E Chelmicka-Schorr; M G Sportiello; S F Atweh; Barry G W Arnason
Response of C-6 glioma to isoproterenol and papaverine in vivo depends on beta-adrenergic receptor density.
Annals of neurology 1984;15(1):96-9.
1984: K Miles; S Atweh; G Otten; Barry G W Arnason; E Chelmicka-Schorr
Beta-adrenergic receptors on splenic lymphocytes from axotomized mice.
International journal of immunopharmacology 1984;6(3):171-7.
1983: E Chelmicka-Schorr; M G Sportiello; G R Otten; Barry G W Arnason
Toxicity of methyldopa (Aldomet) to mouse neuroblastoma cells in vivo.
Cancer research 1983;43(8):3504-6.
1982: E Chelmicka-Schorr; M Sportiello; J P Antel; Barry G W Arnason
Acid protease activity in spinal cord and muscle in wobbler mouse.
Journal of the neurological sciences 1982;56(2-3):141-5.
1982: J P Antel; E Chelmicka-Schorr; M Sportiello; K Stefansson; Robert L Wollmann; Barry G W Arnason
Muscle acid protease activity in amyotrophic lateral sclerosis: correlation with clinical and pathologic features.
Neurology 1982;32(8):901-3.
1981: K Miles; J Quintáns; E Chelmicka-Schorr; Barry G W Arnason
The sympathetic nervous system modulates antibody response to thymus-independent antigens.
Journal of neuroimmunology 1981;1(1):101-5.